St. Jude Medical (STJ) 78.65 $STJ St. Jude Medi
Post# of 273256
Posted On: 09/06/2016 9:02:14 AM
St. Jude Medical (STJ) 78.65 $STJ
St. Jude Medical (STJ) Launches Trial for Amulet Occluder
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 8:54AM CDT
St. Jude Medical, Inc. (STJ), a global medical device company, announced that it has initiated a trial for its AMPLATZER Amulet occlude.
MASI: 59.90 (+0.47), QDEL: 21.58 (-0.16), STJ: 78.65 (+0.51), IDXX: 114.09 (+0.93)
St Jude Medical Has Returned 44.2% Since SmarTrend Recommendation (STJ)
Comtex SmarTrend(R) - Fri Sep 02, 12:51AM CDT
SmarTrend identified an Uptrend for St Jude Medical (NYSE:STJ) on February 22nd, 2016 at $54.18. In approximately 6 months, St Jude Medical has returned 44.22% as of today's recent price of $78.14.
STJ: 78.65 (+0.51)
St. Jude Medical Launches Global Clinical Trial to Evaluate a New Therapy Option for Patients at an Increased Risk of Stroke Due to Atrial Fibrillation
BusinessWire - Thu Sep 01, 8:00AM CDT
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the start of the St. Jude Medical AMPLATZER(TM) Amulet(TM) IDE trial, which will evaluate the safety and effectiveness of the company's AMPLATZER(TM) Amulet(TM) Left Atrial Appendage Occluder used to close the left atrial appendage (LAA) in patients diagnosed with non-valvular atrial fibrillation (AF). The first implant of the study took place at North Mississippi Medical Center in Tupelo, Mississippi by Dr. Jim Stone.
STJ: 78.65 (+0.51)
Post Earnings Coverage as Medtronic Earnings Surge 13 Percent on Lower Tax Bill
ACCESSWIRE - Tue Aug 30, 8:16AM CDT
LONDON, UK / ACCESSWIRE / August 30, 2016 / Active Wall St. announces its post-earnings coverage on Medtronic PLC (NYSE: MDT). The company reported its first quarter fiscal 2016 results on August 25, 2016. The world's largest standalone medical device maker reported better-than-expected quarterly earnings, despite a drop in sales. Register with us now for your free membership at: http://www.activewallst.com/register/.
ABT: 42.09 (-0.21), MDT: 87.32 (+0.34), STJ: 78.65 (+0.51)
St. Jude Medical Continues to Refute Allegations made by Muddy Waters Capital and MedSec
BusinessWire - Tue Aug 30, 7:30AM CDT
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today issued the following statement:
STJ: 78.65 (+0.51)
Media Statement from St. Jude Children's Research Hospital®
PR Newswire - Fri Aug 26, 6:38PM CDT
St. Jude Children's Research Hospital® is not affiliated with St. Jude Medical in any way. Founded by the late entertainer Danny Thomas and located in Memphis, Tennessee, St. Jude Children's Research Hospital is a nonprofit pediatric cancer research hospital. St. Jude Medical is a publicly traded company. There are many organizations that use St. Jude in their names, but there is only one St. Jude Children's Research Hospital dedicated to finding cures for children fighting cancer and other life-threatening diseases.
STJ: 78.65 (+0.51)
St. Jude Medical Refutes Muddy Waters Device Security Allegations and Reinforces Security of Devices and Commitment to Patient Safety
BusinessWire - Fri Aug 26, 2:35PM CDT
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today issued the following statement: We have examined the allegations made by Capital and MedSec on August 25, 2016 regarding the safety and security of our pacemakers and defibrillators, and while we would have preferred the opportunity to review a detailed account of the information, based on available information, we conclude that the report is false and misleading. Our top priority is to reassure our patients, caregivers and physicians that our devices are secure and to ensure ongoing access to the proven clinical benefits of remote monitoring. St. Jude Medical stands behind the security and safety of our devices as confirmed by independent third parties and supported through our regulatory submissions.
STJ: 78.65 (+0.51)
Stock Market News for August 26, 2016
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 9:09AM CDT
Benchmarks finished in the red on Thursday as investors refrained from making big bets ahead of Fed Chief Janet Yellen’s speech at Jackson Hole, Wyoming today
MNK: 72.42 (-3.17), TSLA: 199.70 (+1.92), ENDP: 19.89 (+0.07), F: 12.49 (-0.01), MDT: 87.32 (+0.34), GME: 28.39 (+0.36), MYL: 40.05 (+0.08), PDCO: 46.89 (+0.86), TIF: 70.08 (-0.29), BA: 131.16 (+1.26), ESRX: 72.54 (+0.32), STJ: 78.65 (+0.51), SSYS: 23.30 (+1.37), TECD: 73.33 (-0.01), ADSK: 68.01 (+0.64)
St Jude Medical Has Returned 39.9% Since SmarTrend Recommendation (STJ)
Comtex SmarTrend(R) - Thu Aug 25, 12:49PM CDT
SmarTrend identified an Uptrend for St Jude Medical (NYSE:STJ) on February 22nd, 2016 at $54.18. In approximately 6 months, St Jude Medical has returned 39.94% as of today's recent price of $75.82.
STJ: 78.65 (+0.51)
Watch for St Jude Medical to Potentially Rebound After Falling 7.79% Yesterday
Comtex SmarTrend(R) - Thu Aug 25, 11:46AM CDT
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $73.40 to a high of $81.99. Yesterday, the shares fell 7.8%, which took the trading range below the 3-day low of $81.79 on volume of 21.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
STJ: 78.65 (+0.51)
SmarTrend Watching for Potential Rebound in Shares of St Jude Medical After 7.79% Loss
Comtex SmarTrend(R) - Thu Aug 25, 11:44AM CDT
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $73.40 to a high of $81.99. Yesterday, the shares fell 7.8%, which took the trading range below the 3-day low of $81.79 on volume of 21.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
STJ: 78.65 (+0.51)
Veritas to Usher in the Future of Information Management at Vision 2016 Conference
BusinessWire - Wed Aug 24, 11:01AM CDT
Veritas, the leader in information management, is bringing together a wide range of industry and technology leaders at its Veritas Vision 2016 conference on September 12-14, 2016 at the Aria Resort and Casino in Las Vegas, NV. Register now for a conference and expo pass.
BSX: 24.26 (-0.07), STJ: 78.65 (+0.51)
Medical Equipment Stocks Technical Reports -- St. Jude Medical, Wright Medical, Edwards Lifesciences, and Steris
PR Newswire - Tue Aug 23, 7:05AM CDT
This morning's stocks in focus on Stock-Callers.com belong in the Healthcare sector which rose 0.3% in midday trading on Monday, August 22, 2016. As per Forbes, the Health Care Select Sector SPDR ETF (XLV) climbed 0.2%, up 4.21% on an YTD basis. Let us now review the following Medical Appliances and Equipment equities and see how they fared at the close: St. Jude Medical Inc. (NYSE: STJ), Wright Medical Group N.V. (NASDAQ: WMGI), Edwards Lifesciences Corp. (NYSE: EW), and Steris PLC (NYSE: STE). Download the free research reports on these stocks today:
WMGI: 24.71 (+0.10), STE: 71.00 (+0.89), EW: 115.85 (-0.02), STJ: 78.65 (+0.51), WMGIZ: 1.35 (unch)
St Jude Medical Shares Up 53.6% Since SmarTrend's Buy Recommendation (STJ)
Comtex SmarTrend(R) - Thu Aug 18, 12:21AM CDT
SmarTrend identified an Uptrend for St Jude Medical (NYSE:STJ) on February 22nd, 2016 at $54.18. In approximately 6 months, St Jude Medical has returned 53.56% as of today's recent price of $83.20.
STJ: 78.65 (+0.51)
Global Spinal Cord Stimulation Devices Market 2016-2020 with Boston Scientific, Medtronic, Nevro & St. Jude Medical Dominating - Research and Markets
BusinessWire - Thu Aug 11, 8:58AM CDT
Research and Markets has announced the addition of the "Global Spinal Cord Stimulation Devices Market 2016-2020" report to their offering.
STJ: 78.65 (+0.51)
High Unmet Medical Needs in Emerging Economies to Fuel Demand for Pain Management Devices, says TMR
GlobeNewswire - Mon Aug 08, 5:25AM CDT
The dynamic nature of the global market for pain management devices has set in motion strong competition between players. The top three participants, namely Medtronic Plc, St. Jude Medical Inc., and Boston Scientific Corp. collectively accounted for more than 72% of the overall market in 2014, reports Transparency Market Research (TMR) in a new study.
MDT: 87.32 (+0.34), STJ: 78.65 (+0.51)
Watch for Shares of St Jude Medical (STJ) to Approach Support at $83.20
Comtex SmarTrend(R) - Thu Aug 04, 8:44AM CDT
Shares of St Jude Medical (NYSE:STJ) have bearishly opened below the pivot of $83.46 today and have reached the first support level of $83.37. Should the shares continue to fall, the support pivots of $83.20 and $82.94 will be of interest.
STJ: 78.65 (+0.51)
St. Jude Medical Announces Third Quarter Dividend
BusinessWire - Wed Aug 03, 3:17PM CDT
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that its Board of Directors declared a third quarter dividend of $0.31 per common share of the Company's stock. This dividend amount is equal to the dividend paid during the first and second quarters of 2016 and brings the total dividend declared for the year to $0.93 per share. The dividend is payable October 28, 2016, to shareholders of record at the close of business on September 30, 2016.
STJ: 78.65 (+0.51)
Booming Medical Tourism Industry in Emerging Economies to Propel Global Cardiovascular Monitoring and Diagnostic Devices Market, Reports TMR
PR Newswire - Wed Aug 03, 5:30AM CDT
Intense competition and high entry barriers outline the present state of the competitive landscape of the global cardiovascular monitoring and diagnostic devices market, states a recent Transparency Market Research (TMR) report. In the markedly consolidated market, the top two vendors, GE Healthcare and Philips Healthcare, accounted for a more than 55% share in 2015. Moreover, these two companies have their headquarters in Europe, granting this regional market a high level of saturation. The other half of the competitive landscape is, however, highly fragmented with a large number of specialty vendors operating in regional pockets.
STJ: 78.65 (+0.51)
St. Jude Medical (STJ) Launches Trial for Amulet Occluder
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 8:54AM CDT
St. Jude Medical, Inc. (STJ), a global medical device company, announced that it has initiated a trial for its AMPLATZER Amulet occlude.
MASI: 59.90 (+0.47), QDEL: 21.58 (-0.16), STJ: 78.65 (+0.51), IDXX: 114.09 (+0.93)
St Jude Medical Has Returned 44.2% Since SmarTrend Recommendation (STJ)
Comtex SmarTrend(R) - Fri Sep 02, 12:51AM CDT
SmarTrend identified an Uptrend for St Jude Medical (NYSE:STJ) on February 22nd, 2016 at $54.18. In approximately 6 months, St Jude Medical has returned 44.22% as of today's recent price of $78.14.
STJ: 78.65 (+0.51)
St. Jude Medical Launches Global Clinical Trial to Evaluate a New Therapy Option for Patients at an Increased Risk of Stroke Due to Atrial Fibrillation
BusinessWire - Thu Sep 01, 8:00AM CDT
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the start of the St. Jude Medical AMPLATZER(TM) Amulet(TM) IDE trial, which will evaluate the safety and effectiveness of the company's AMPLATZER(TM) Amulet(TM) Left Atrial Appendage Occluder used to close the left atrial appendage (LAA) in patients diagnosed with non-valvular atrial fibrillation (AF). The first implant of the study took place at North Mississippi Medical Center in Tupelo, Mississippi by Dr. Jim Stone.
STJ: 78.65 (+0.51)
Post Earnings Coverage as Medtronic Earnings Surge 13 Percent on Lower Tax Bill
ACCESSWIRE - Tue Aug 30, 8:16AM CDT
LONDON, UK / ACCESSWIRE / August 30, 2016 / Active Wall St. announces its post-earnings coverage on Medtronic PLC (NYSE: MDT). The company reported its first quarter fiscal 2016 results on August 25, 2016. The world's largest standalone medical device maker reported better-than-expected quarterly earnings, despite a drop in sales. Register with us now for your free membership at: http://www.activewallst.com/register/.
ABT: 42.09 (-0.21), MDT: 87.32 (+0.34), STJ: 78.65 (+0.51)
St. Jude Medical Continues to Refute Allegations made by Muddy Waters Capital and MedSec
BusinessWire - Tue Aug 30, 7:30AM CDT
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today issued the following statement:
STJ: 78.65 (+0.51)
Media Statement from St. Jude Children's Research Hospital®
PR Newswire - Fri Aug 26, 6:38PM CDT
St. Jude Children's Research Hospital® is not affiliated with St. Jude Medical in any way. Founded by the late entertainer Danny Thomas and located in Memphis, Tennessee, St. Jude Children's Research Hospital is a nonprofit pediatric cancer research hospital. St. Jude Medical is a publicly traded company. There are many organizations that use St. Jude in their names, but there is only one St. Jude Children's Research Hospital dedicated to finding cures for children fighting cancer and other life-threatening diseases.
STJ: 78.65 (+0.51)
St. Jude Medical Refutes Muddy Waters Device Security Allegations and Reinforces Security of Devices and Commitment to Patient Safety
BusinessWire - Fri Aug 26, 2:35PM CDT
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today issued the following statement: We have examined the allegations made by Capital and MedSec on August 25, 2016 regarding the safety and security of our pacemakers and defibrillators, and while we would have preferred the opportunity to review a detailed account of the information, based on available information, we conclude that the report is false and misleading. Our top priority is to reassure our patients, caregivers and physicians that our devices are secure and to ensure ongoing access to the proven clinical benefits of remote monitoring. St. Jude Medical stands behind the security and safety of our devices as confirmed by independent third parties and supported through our regulatory submissions.
STJ: 78.65 (+0.51)
Stock Market News for August 26, 2016
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 9:09AM CDT
Benchmarks finished in the red on Thursday as investors refrained from making big bets ahead of Fed Chief Janet Yellen’s speech at Jackson Hole, Wyoming today
MNK: 72.42 (-3.17), TSLA: 199.70 (+1.92), ENDP: 19.89 (+0.07), F: 12.49 (-0.01), MDT: 87.32 (+0.34), GME: 28.39 (+0.36), MYL: 40.05 (+0.08), PDCO: 46.89 (+0.86), TIF: 70.08 (-0.29), BA: 131.16 (+1.26), ESRX: 72.54 (+0.32), STJ: 78.65 (+0.51), SSYS: 23.30 (+1.37), TECD: 73.33 (-0.01), ADSK: 68.01 (+0.64)
St Jude Medical Has Returned 39.9% Since SmarTrend Recommendation (STJ)
Comtex SmarTrend(R) - Thu Aug 25, 12:49PM CDT
SmarTrend identified an Uptrend for St Jude Medical (NYSE:STJ) on February 22nd, 2016 at $54.18. In approximately 6 months, St Jude Medical has returned 39.94% as of today's recent price of $75.82.
STJ: 78.65 (+0.51)
Watch for St Jude Medical to Potentially Rebound After Falling 7.79% Yesterday
Comtex SmarTrend(R) - Thu Aug 25, 11:46AM CDT
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $73.40 to a high of $81.99. Yesterday, the shares fell 7.8%, which took the trading range below the 3-day low of $81.79 on volume of 21.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
STJ: 78.65 (+0.51)
SmarTrend Watching for Potential Rebound in Shares of St Jude Medical After 7.79% Loss
Comtex SmarTrend(R) - Thu Aug 25, 11:44AM CDT
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $73.40 to a high of $81.99. Yesterday, the shares fell 7.8%, which took the trading range below the 3-day low of $81.79 on volume of 21.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
STJ: 78.65 (+0.51)
Veritas to Usher in the Future of Information Management at Vision 2016 Conference
BusinessWire - Wed Aug 24, 11:01AM CDT
Veritas, the leader in information management, is bringing together a wide range of industry and technology leaders at its Veritas Vision 2016 conference on September 12-14, 2016 at the Aria Resort and Casino in Las Vegas, NV. Register now for a conference and expo pass.
BSX: 24.26 (-0.07), STJ: 78.65 (+0.51)
Medical Equipment Stocks Technical Reports -- St. Jude Medical, Wright Medical, Edwards Lifesciences, and Steris
PR Newswire - Tue Aug 23, 7:05AM CDT
This morning's stocks in focus on Stock-Callers.com belong in the Healthcare sector which rose 0.3% in midday trading on Monday, August 22, 2016. As per Forbes, the Health Care Select Sector SPDR ETF (XLV) climbed 0.2%, up 4.21% on an YTD basis. Let us now review the following Medical Appliances and Equipment equities and see how they fared at the close: St. Jude Medical Inc. (NYSE: STJ), Wright Medical Group N.V. (NASDAQ: WMGI), Edwards Lifesciences Corp. (NYSE: EW), and Steris PLC (NYSE: STE). Download the free research reports on these stocks today:
WMGI: 24.71 (+0.10), STE: 71.00 (+0.89), EW: 115.85 (-0.02), STJ: 78.65 (+0.51), WMGIZ: 1.35 (unch)
St Jude Medical Shares Up 53.6% Since SmarTrend's Buy Recommendation (STJ)
Comtex SmarTrend(R) - Thu Aug 18, 12:21AM CDT
SmarTrend identified an Uptrend for St Jude Medical (NYSE:STJ) on February 22nd, 2016 at $54.18. In approximately 6 months, St Jude Medical has returned 53.56% as of today's recent price of $83.20.
STJ: 78.65 (+0.51)
Global Spinal Cord Stimulation Devices Market 2016-2020 with Boston Scientific, Medtronic, Nevro & St. Jude Medical Dominating - Research and Markets
BusinessWire - Thu Aug 11, 8:58AM CDT
Research and Markets has announced the addition of the "Global Spinal Cord Stimulation Devices Market 2016-2020" report to their offering.
STJ: 78.65 (+0.51)
High Unmet Medical Needs in Emerging Economies to Fuel Demand for Pain Management Devices, says TMR
GlobeNewswire - Mon Aug 08, 5:25AM CDT
The dynamic nature of the global market for pain management devices has set in motion strong competition between players. The top three participants, namely Medtronic Plc, St. Jude Medical Inc., and Boston Scientific Corp. collectively accounted for more than 72% of the overall market in 2014, reports Transparency Market Research (TMR) in a new study.
MDT: 87.32 (+0.34), STJ: 78.65 (+0.51)
Watch for Shares of St Jude Medical (STJ) to Approach Support at $83.20
Comtex SmarTrend(R) - Thu Aug 04, 8:44AM CDT
Shares of St Jude Medical (NYSE:STJ) have bearishly opened below the pivot of $83.46 today and have reached the first support level of $83.37. Should the shares continue to fall, the support pivots of $83.20 and $82.94 will be of interest.
STJ: 78.65 (+0.51)
St. Jude Medical Announces Third Quarter Dividend
BusinessWire - Wed Aug 03, 3:17PM CDT
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that its Board of Directors declared a third quarter dividend of $0.31 per common share of the Company's stock. This dividend amount is equal to the dividend paid during the first and second quarters of 2016 and brings the total dividend declared for the year to $0.93 per share. The dividend is payable October 28, 2016, to shareholders of record at the close of business on September 30, 2016.
STJ: 78.65 (+0.51)
Booming Medical Tourism Industry in Emerging Economies to Propel Global Cardiovascular Monitoring and Diagnostic Devices Market, Reports TMR
PR Newswire - Wed Aug 03, 5:30AM CDT
Intense competition and high entry barriers outline the present state of the competitive landscape of the global cardiovascular monitoring and diagnostic devices market, states a recent Transparency Market Research (TMR) report. In the markedly consolidated market, the top two vendors, GE Healthcare and Philips Healthcare, accounted for a more than 55% share in 2015. Moreover, these two companies have their headquarters in Europe, granting this regional market a high level of saturation. The other half of the competitive landscape is, however, highly fragmented with a large number of specialty vendors operating in regional pockets.
STJ: 78.65 (+0.51)
(0)
(0)Scroll down for more posts ▼